NO962748D0 - Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og medisinsk anvendelse derav - Google Patents

Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og medisinsk anvendelse derav

Info

Publication number
NO962748D0
NO962748D0 NO962748A NO962748A NO962748D0 NO 962748 D0 NO962748 D0 NO 962748D0 NO 962748 A NO962748 A NO 962748A NO 962748 A NO962748 A NO 962748A NO 962748 D0 NO962748 D0 NO 962748D0
Authority
NO
Norway
Prior art keywords
group
pharmaceutically acceptable
hydrocarbon group
atom
acceptable salts
Prior art date
Application number
NO962748A
Other languages
English (en)
Other versions
NO962748L (no
NO314730B1 (no
Inventor
Ryohei Kato
Tsutomu Mimoto
Tominaga Fukazawa
Naoko Morohashi
Yoshiaki Kiso
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO962748D0 publication Critical patent/NO962748D0/no
Publication of NO962748L publication Critical patent/NO962748L/no
Publication of NO314730B1 publication Critical patent/NO314730B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO19962748A 1995-06-30 1996-06-28 Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og anvendelse derav til fremstilling av preparater, samt anti-AIDS-middelog fremgangsmåte for fremstilling av slike forbindelser NO314730B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18815195 1995-06-30
JP14067896 1996-05-10

Publications (3)

Publication Number Publication Date
NO962748D0 true NO962748D0 (no) 1996-06-28
NO962748L NO962748L (no) 1997-01-02
NO314730B1 NO314730B1 (no) 2003-05-12

Family

ID=26473119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19962748A NO314730B1 (no) 1995-06-30 1996-06-28 Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og anvendelse derav til fremstilling av preparater, samt anti-AIDS-middelog fremgangsmåte for fremstilling av slike forbindelser

Country Status (9)

Country Link
US (2) US5932550A (no)
EP (1) EP0751145B1 (no)
AT (1) ATE266039T1 (no)
AU (1) AU705193B2 (no)
CA (1) CA2179935C (no)
DE (1) DE69632365T2 (no)
DK (1) DK0751145T3 (no)
ES (1) ES2220963T3 (no)
NO (1) NO314730B1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313094B1 (en) 1990-12-11 2001-11-06 Japan Energy Corporation β-amino-α-hydroxycarboxylic acid derivatives and HIV protease inhibitors
US6803466B1 (en) * 1997-12-08 2004-10-12 The Scripps Research Institute HIV/FIV protease inhibitors having a small P3 residue
AU1904599A (en) * 1997-12-08 1999-06-28 Scripps Research Institute, The Hiv/fiv protease inhibitors having a small p3 residue
WO2001047948A1 (fr) * 1999-12-28 2001-07-05 Japan Energy Corporation Nouveau composé dipeptidique et ses applications en médecine
US6589962B1 (en) 1999-07-20 2003-07-08 Merck & Co., Inc. Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof
PL354122A1 (en) * 1999-08-09 2003-12-29 Tripep Abtripep Ab Pharmaceutical compositions containing tripeptides
US6287688B1 (en) * 2000-03-03 2001-09-11 E. I. Du Pont De Nemours And Company Partially oriented poly(trimethylene terephthalate) yarn
US7094909B2 (en) * 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US6593455B2 (en) * 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
WO2003024995A1 (en) * 2001-09-19 2003-03-27 Tripep Ab Molecules that block viral infectivity and methods of use thereof
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
US20040180893A1 (en) * 2003-02-21 2004-09-16 Balzarini Jan Maria Rene Identification of compounds that inhibit replication of human immunodeficiency virus
US6955002B2 (en) * 2003-03-18 2005-10-18 Sandel Medical Industries Llc Medication marking system
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
BRPI0417223A (pt) * 2003-12-04 2007-03-06 Pfizer métodos de preparar compostos úteis como inibidores de protease
BRPI0417248A (pt) * 2003-12-04 2007-03-06 Pfizer métodos de preparação de compostos utilizáveis como inibidores de protease
EP1737818A2 (en) * 2003-12-04 2007-01-03 Pfizer, Inc. Methods for the preparation of stereoisomerically enriched amines
EP2714662B1 (en) 2011-05-31 2017-10-11 Theravance Biopharma R&D IP, LLC Neprilysin inhibitors
JP5885832B2 (ja) * 2011-05-31 2016-03-16 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ネプリライシン阻害剤
CA2835220A1 (en) 2011-05-31 2012-12-06 Theravance, Inc. Neprilysin inhibitors

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395664A1 (en) * 1987-10-21 1990-11-07 The Upjohn Company Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
US4963655A (en) * 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
US5342922A (en) * 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease
US5086165A (en) * 1989-03-08 1992-02-04 Washington University Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond
DE3913272A1 (de) * 1989-04-22 1990-10-25 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung
US5126326A (en) * 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives
US5212157A (en) * 1989-06-06 1993-05-18 Bio-Mega, Inc. Enzyme inhibitors
DE4001236A1 (de) * 1990-01-18 1991-07-25 Bayer Ag Neue peptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, insbesondere als arzneimittel gegen retroviren
EP0438311A3 (en) * 1990-01-19 1992-07-01 Merck & Co. Inc. Di- and tripeptide renin inhibitors
EP0546115A1 (en) * 1990-08-24 1993-06-16 The Upjohn Company Peptides containing amino-polyols as transition-state mimics
US5187074A (en) * 1990-10-11 1993-02-16 Merck & Co., Inc. Method of hydroxylation with ATCC 55086
US5192668A (en) * 1990-10-11 1993-03-09 Merck & Co., Inc. Synthesis of protease inhibitor
US5188950A (en) * 1990-10-11 1993-02-23 Merck & Co., Inc. Method of preparing HIV protease inhibitors
US5475013A (en) * 1990-11-19 1995-12-12 Monsanto Company Retroviral protease inhibitors
EP0559793A1 (en) * 1990-11-30 1993-09-15 Smithkline Beecham Corporation Hiv protease inhibitors
CA2056911C (en) * 1990-12-11 1998-09-22 Yuuichi Nagano Hiv protease inhibitors
IL100899A (en) * 1991-02-08 1997-06-10 Sankyo Co Beta-amino-alpha- hydroxycarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IE922316A1 (en) * 1991-07-17 1993-01-27 Smithkline Beecham Corp Retroviral protease inhibitors
WO1993008184A1 (en) * 1991-10-23 1993-04-29 Merck & Co., Inc. Hiv protease inhibitors
US5644028A (en) * 1992-05-13 1997-07-01 Japan Energy Corporation Process for producing peptide derivatives and salts therefor
ZA935697B (en) * 1992-08-07 1994-03-10 Sankyo Co Peptides capable of inhibiting the activity of hiv protease their preparation and their therapeutic use
US5434265A (en) * 1992-12-22 1995-07-18 Eli Lilly And Company Inhibitors of HIV protease
US5554653A (en) * 1992-12-22 1996-09-10 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
ES2150933T3 (es) * 1992-12-22 2000-12-16 Lilly Co Eli Inhibidores de la proteasa vih utiles para el tratamiento del sida.
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
AU6135294A (en) * 1993-02-12 1994-08-29 Merck & Co., Inc. Piperazine derivatives as hiv protease inhibitors
AU6828894A (en) * 1993-05-14 1994-12-12 Merck & Co., Inc. Hiv protease inhibitors
US5587514A (en) * 1993-11-08 1996-12-24 Emory University Diastereoselective synthesis of hydroxyethylene dipeptide isosteres
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
US5492910A (en) * 1994-11-17 1996-02-20 Bristol-Myers Squibb Co. Retrocarbamate protease inhibitors
WO1996028423A1 (fr) * 1995-03-15 1996-09-19 Sankyo Company, Limited Composes dipeptidiques de structure ahpba

Also Published As

Publication number Publication date
AU705193B2 (en) 1999-05-20
DK0751145T3 (da) 2004-08-30
EP0751145A2 (en) 1997-01-02
CA2179935A1 (en) 1996-12-31
CA2179935C (en) 2010-09-07
US5932550A (en) 1999-08-03
NO962748L (no) 1997-01-02
ES2220963T3 (es) 2004-12-16
US5962640A (en) 1999-10-05
AU5628596A (en) 1997-02-06
NO314730B1 (no) 2003-05-12
EP0751145B1 (en) 2004-05-06
ATE266039T1 (de) 2004-05-15
DE69632365T2 (de) 2005-05-04
DE69632365D1 (de) 2004-06-09
EP0751145A3 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
NO962748D0 (no) Nye dipeptidforbindelser eller farmasöytisk akseptable salter derav og medisinsk anvendelse derav
ATE156116T1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
NO950297D0 (no) Prolinamidderivater
NO941278D0 (no) Sykliske ureaer og analoger som er anvendbare som retrovirale proteaseinhibitorer
NO993706L (no) Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet
KR910009640A (ko) 헤테로고리옥시 페녹시아세트산유도체 및 제초제로서의 그의 용도
ATE358484T1 (de) Antidiabetische medikamente
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
HU9300729D0 (en) Method for producing substituted pyrrholidine derivatives of hiv-protease inhibitor effect and medical preparatives containing them
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
DK0417746T3 (da) N-Azabicyclo(3.3.0)octanamider af aromatiske syrer
EP1433479B8 (en) Appetite-stimulating agents and remedies for anorexia
AU636644B2 (en) N-hydroxy-dibenz(b,e)oxepin-alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments
DE69220371D1 (de) Hemmstoff der blutgefässhypertrophie
ATE158503T1 (de) Aids-virus-infektion hemmende zusammensetzung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees